Delivery Order SPE2DB20D3111-SPE2DB25FA8CM

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a ceiling value of $7,403.25 and is a Firm Fixed Price contract. The period of performance extends through June 9, 2025. This contract is not set aside and was awarded on an open competitive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a firm fixed price, a ceiling value of $5,103.58, and a period of performance extending to May 19, 2025. The contract is not designated as a set-aside. As a prime contractor, AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract is a firm fixed-price delivery order with a ceiling value of $1,501.50 and a completion date of June 12, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract has a ceiling value of $3,318.41 and a completion date of November 18, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a firm fixed-price structure and a ceiling value of $2,452.33, with an ultimate completion date of May 21, 2025. The contract is not set aside for any specific business type....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a ceiling value of $3,003.00 and is a firm fixed-price delivery order that runs until January 31, 2025. The contract was awarded on January 30, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,576.14 firm fixed-price contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has a period of performance through February 25, 2025 and was awarded on February 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,225.83, is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of April 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,172.99 firm fixed-price contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The contract has an ultimate completion date of March 25, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a ceiling value of $2,589.86 and runs through February 25, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA8CM
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a firm-fixed price and a ceiling value of $2,633.37. The period of performance ends on June 11, 2025. This contract is not designated as a set-aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/9/25, 1:00 PM